#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diffuse large B-cell lymphoma Frostbite Primary mediastinal large B-cell lymphoma Thrombocytopenia Ichthyosis Acute graft versus host disease Palmoplantar pustulosis Ureteric cancer Anal cancer Small for dates baby Adenocarcinoma pancreas Non-renal cell carcinoma of kidney Phenylketonuria Retinopathy proliferative Kawasaki's disease More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Treatment Advanced systemic mastocytosis – Basic Information Thrombotic thrombocytopenic purpura – Trials in Disease Loeys-Dietz syndrome – Treatment Skin angiosarcoma Pelizaeus-Merzbacher disease – Trials in Disease Wiskott-Aldrich syndrome Lymphatic malformation Mantle cell lymphoma stage II – Life with Disease Brain stem glioma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Asfotase Alfa Zanubrutinib Clascoterone Levothyroxine Roginolisib Naloxone Brinzolamide Clavulanic Acid Sodium Phosphate Dodecahydrate HYDROGEN GSKVX000000044501 HUPERZINE A Bay 3283142 Dextromethadone Hydrochloride Timothy Grass Pollen Extract Lutropin Alfa ANTIMETABOLITES Olmesartan Medoxomil Tafasitamab Dextrose Bp More therapies…

    Learn about Your Condition

    Orthostatic hypotension Primary myelofibrosis Bacterial vaginosis Depression Frostbite Hypotonia Autoimmune haemolytic anaemia Neurodegenerative disorder Brain cancer metastatic Hyperoxaluria Systemic sclerosis pulmonary Type IIa hyperlipidaemia Tendon rupture Guttate psoriasis Metastatic gastric cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • A study testing the safety and effectiveness of infigratinib compared to placebo in infants and young children with achondroplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Infigratinib
    Norway Spain

  • A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic kidney disease
    • Alport’s syndrome
    Czechia France Germany Italy Poland Portugal +1

  • A study of long-term safety and effectiveness of denecimig in people with haemophilia A with or without inhibitors

    Recruiting

    3 1 1
    Austria Belgium Bulgaria Denmark France Germany +10

  • A Study Comparing Gadopiclenol and Gadoterate Meglumine for Heart MRI Scans in Children with Congenital Heart Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Meglumine Gadoterate
    Spain

  • Comparing morphine alone to morphine and lidocaine for pain relief in sickle cell anemia patients with vaso-occlusive crisis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Morphine Hydrochloride
    • Lidocaine Hydrochloride
    Belgium

  • A study of navenibart for long-term safety in patients with hereditary angioedema

    Recruiting

    3 1
    Investigated Drugs:
    • NAVENIBART
    Austria Bulgaria Czechia France Germany Hungary +5
Previous Page
1 2 3 4 5 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!